Michelle Link Sells 4,039 Shares of Maximus (NYSE:MMS) Stock

Maximus, Inc. (NYSE:MMS) insider Michelle Link sold 4,039 shares of the firm’s stock in a transaction that occurred on Wednesday, December 3rd. The stock was sold at an average price of $86.84, for a total value of $350,746.76. Following the sale, the insider directly owned 19,542 shares of the company’s stock, valued at $1,697,027.28. This represents a 17.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Maximus Stock Down 1.9%

NYSE:MMS traded down $1.66 during trading hours on Wednesday, reaching $84.85. The company had a trading volume of 599,506 shares, compared to its average volume of 572,281. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $92.50. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.77. The firm has a market cap of $4.62 billion, a price-to-earnings ratio of 15.26 and a beta of 0.56. The business’s 50-day simple moving average is $85.56 and its two-hundred day simple moving average is $80.24.

Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, November 20th. The health services provider reported $1.62 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.01). Maximus had a return on equity of 25.23% and a net margin of 5.87%.The company had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.34 billion. During the same period last year, the company earned $1.46 EPS. Maximus’s revenue for the quarter was up .2% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. On average, equities analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 1st. Shareholders of record on Friday, November 14th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date was Friday, November 14th. Maximus’s dividend payout ratio is 21.58%.

Analysts Set New Price Targets

A number of brokerages have recently commented on MMS. Weiss Ratings raised Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday. Zacks Research lowered shares of Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 27th. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $90.00.

Institutional Trading of Maximus

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Dimensional Fund Advisors LP boosted its position in Maximus by 2.0% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider’s stock valued at $170,812,000 after buying an additional 36,989 shares during the period. Fuller & Thaler Asset Management Inc. grew its position in shares of Maximus by 40.0% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider’s stock worth $117,921,000 after buying an additional 494,372 shares during the last quarter. AQR Capital Management LLC raised its holdings in shares of Maximus by 177.2% during the first quarter. AQR Capital Management LLC now owns 1,173,329 shares of the health services provider’s stock valued at $79,341,000 after acquiring an additional 750,031 shares in the last quarter. Boston Partners lifted its stake in Maximus by 47.0% in the third quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock worth $88,236,000 after acquiring an additional 308,892 shares during the period. Finally, Reinhart Partners LLC. boosted its holdings in Maximus by 0.8% in the third quarter. Reinhart Partners LLC. now owns 921,578 shares of the health services provider’s stock valued at $84,206,000 after acquiring an additional 7,722 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.